Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian indices continue rise
Thu, 9 Apr Closing

The Indian benchmark indices, Sensex and NSE-Nifty advanced for fifth day in a row after international credit rating agency Moody's upgraded India's sovereign ratings outlook to 'positive' from stable'. Reacting to this development, the banking stocks were in high demand. Majority of the other sectoral indices were trading in the green. However, Healthcare, Realty and capital goods witnessed maximum selling pressure. Nifty closed today's session with a gain of 0.7% or 63 points while Sensex closed today's session with a profit of 0.62% or 178 points. S&P BSE Midcap and S&P BSE Smallcap ended the volatile session with 0.25% and 0.71% gains, respectively.

As regards global markets, most other Asian indices closed lower today while European indices have opened in the positive. The rupee was placed at Rs 62.44 to the dollar at the time of writing.

Healthcare stocks languished in the red today with Biocon Ltd and Wockhardt Ltd being the leading losers. According to a leading financial daily, Drugmaker Cipla has entered into an agreement to acquire 100% stake in Brazil's Duomed Produtos Farmaceuticos Ltda, for about Rs 260 m. The acquisition is part of Cipla's front-end strategy and will expedite its product registrations in Brazil, it said, adding that the transaction was expected to be completed by the end of May 2015. Through its UK-based wholly-owned subsidiary, Cipla (EU) Ltd, the company inked the agreement with the limited liability company in Brazil for a cash consideration of Brazilian Real (R$) 12.9 million.

A sell-off was observed in the auto sector with Escorts and Eicher Motors bearing most of the brunt. According to a leading financial daily, Mahindra & Mahindra (M&M) has acquired 450 acres land at Cheyyarin Thiruvannamalai district in Tamil Nadu to set up a greenfield automobile plant. The company would invest about Rs 40 bn in this plant in two phases. The company will be setting up a test track in the Phase-I, followed an automotive plant. The government will be signing a memorandum of understanding with the company during the forthcoming Global Investors' Meet scheduled on May 23 and 24. The scrip of M&M ended the day higher by 0.75% on the BSE.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian indices continue rise". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.